Charles Baum

Dr. Charles M.
Baum is a Chief Executive Officer & Director at Terremoto Biosciences, Inc., an Independent Director at Acrivon Therapeutics, Inc., an Independent Director at PMV Pharmaceuticals, Inc. and a Chairman at Oncomyx Therapeutics, Inc. He is on the Board of Directors at Terremoto Biosciences, Inc., Acrivon Therapeutics, Inc., PMV Pharmaceuticals, Inc. and Crossbow Therapeutics, Inc. Dr. Baum was previously employed as an Independent Director by Poseida Therapeutics, Inc., an Independent Director by BCTG Acquisition Corp., an Independent Director by Immunomedics, Inc., an Independent Director by Array BioPharma, Inc., a President, Chief Executive Officer & Director by Mirati Therapeutics, Inc., and a Senior VP-Biotherapeutic Clinical Research by Pfizer Inc. He also served on the board at Odyssey Therapeutics, Inc. He received his doctorate degree from Washington University School of Medicine.